Breaking News

Smart Implantable Pumps Market Size Overview by Industry Trends, Share, Growth Factor and Analysis to 2026

As per the American Heart Association, around 46% of the adults in the U.S. are likely to have hypertension. Center from Diseases and Prevention (CDC) states that stroke kills around 1,40,000 people in the U.S. each year. The rising prevalence of heart failure and hypertension is expected to drive the global smart implantable pumps market. These pumps are one of the most advanced drug delivery systems implanted beneath the skin of patients.

Smart implantable pump technology administers steady drug dosage in patients suffering from chronic diseases. Favorable healthcare reimbursement policies by governments and increasing healthcare expenses are factors responsible for smart implantable pumps market growth. With the introduction of wireless technology, the demand for smart implantable pumps is likely to increase. Patients and clinicians can easily monitor and control their implants wirelessly with the help of smartphones. All one needs is Bluetooth function and internet connectivity.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/smart-implantable-pumps-market-101242

Fortune Business Insights offers a detailed overview of the global market in a report, titled “Smart Implantable Pumps Market Size, Share and Global Trend By Type (Micro Pumps, Perfusion Pumps), By Application (Cardiovascular, Pain Control, Others), By End User (Hospitals, Ambulatory Surgery Centers, Others) and Geography Forecast till 2026.” The report offers in-depth insights into the smart implantable pumps market trends, demand forecasts, and covers information on segments such as type, application, end-user, and geography. In addition to this, the report offers a rigorous study on the competitive landscape of the market and adoption of business strategies by key players.

As per type, perfusion pumps are expected to account for a major portion of the smart implantable pumps market share. The improved efficacy offered by this segment than micropumps is the primary factor driving the segment. The demand for smart implantable pump system is expected to increase in ambulatory surgery centers and hospitals worldwide in the foreseeable future, favouring the smart implantable pumps market size.

Request a Sample Copy of the Global Smart Implantable Pumps Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/smart-implantable-pumps-market-101242

Medtronic’s SynchroMed II myPTM Receives FDA Approval to Help Patients Manage Their Pain

As per the report, some of the leading players operating in the global smart implantable pumps market include:

  • Abbott
  • Intarcia Therapeutics, Inc.
  • Medtronic
  • FLOWONIX MEDICAL INC.
  • Cognos Therapeutics, Inc

Companies are planning to establish their presence in the market and offer a wide range of products across the world. For instance, Medtronic announced the launch of a new personal manager therapy called SynchroMed II myPTM Personal Therapy Manager for patients suffering from chronic pain. The product received FDA approval in October 2018. This implantable drug pump offers pain relief with lesser side effects. This can help patients to eliminate the use of oral opioids.

Highlights of the Report

  • In-depth analysis of various insights, namely, Smart Implantable Pumps Market trends, growth drivers, opportunities, and other related challenges.
  • Comprehensive details of key market players, their core competencies, and market shares.
  • The potency of suppliers and buyers to make better business decisions.
  • Lists out the market size in terms of volume.

More Trending Topics From Fortune Business [email protected]

Global Orthopedic Implants Market to Reach USD 64.0 Billion by 2026; Rising Number of Orthopedic Sports Injuries to Favor Growth

Global Dialyzer Market Projected to Reach US$ 13,707.2 mn by the End of 2026: Fortune Business Insights

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

Website: Fortune Business Insights

Follow us on:

LinkedIn | Twitter | Blogs

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Smart Implantable Pumps Market: myPTM by Medtronic Receives FDA Approval to Improve the Patient’s Quality of Life